- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.69 Å
- Oligo State
- monomer
- Ligands
- 1 x YD7: ~{N}-[(5~{R})-2-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-6,7,8,9-tetrahydro-5~{H}-benzo[7]annulen-5-yl]-3-propan-2-yloxy-azetidine-1-carboxamide(Non-covalent)
- 1 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Hopkins, B.T. et al., Discovery and Preclinical Characterization of BIIB091, a Reversible, Selective BTK Inhibitor for the Treatment of Multiple Sclerosis. J.Med.Chem. (2022)
- Release Date
- 2022-01-12
- Peptides
- Isoform BTK-C of Tyrosine-protein kinase BTK: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A